Born Louis J, Harmon John W, Jay Steven M
Fischell Department of Bioengineering University of Maryland College Park Maryland USA.
Department of Surgery and Hendrix Burn/Wound Laboratory Johns Hopkins University School of Medicine Baltimore Maryland USA.
Bioeng Transl Med. 2020 Jul 16;5(3):e10172. doi: 10.1002/btm2.10172. eCollection 2020 Sep.
Both extracellular vesicles (EVs) and long noncoding RNAs (lncRNAs) have been increasingly investigated as biomarkers, pathophysiological mediators, and potential therapeutics. While these two entities have often been studied separately, there are increasing reports of EV-associated lncRNA activity in processes such as oncogenesis as well as tissue repair and regeneration. Given the powerful nature and emerging translational impact of other noncoding RNAs such as microRNA (miRNA) and small interfering RNA, lncRNA therapeutics may represent a new frontier. While EVs are natural vehicles that transport and protect lncRNAs physiologically, they can also be engineered for enhanced cargo loading and therapeutic properties. In this review, we will summarize the activity of lncRNAs relevant to both tissue repair and cancer treatment and discuss the role of EVs in enabling the potential of lncRNA therapeutics.
细胞外囊泡(EVs)和长链非编码RNA(lncRNAs)作为生物标志物、病理生理介质和潜在治疗手段,受到了越来越多的研究。虽然这两个实体通常是分开研究的,但在肿瘤发生以及组织修复和再生等过程中,与EV相关的lncRNA活性的报道越来越多。鉴于微小RNA(miRNA)和小干扰RNA等其他非编码RNA的强大性质和新兴的转化影响,lncRNA治疗可能代表一个新的前沿领域。虽然EV是在生理上运输和保护lncRNAs的天然载体,但它们也可以进行工程改造以增强货物装载和治疗特性。在这篇综述中,我们将总结与组织修复和癌症治疗相关的lncRNAs的活性,并讨论EV在实现lncRNA治疗潜力方面的作用。